Chemomab Therapeutics Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $3.4M | $17.0M | $6.1M |
| FY2025 | $1.5M | $13.8M | $7.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $3.4M | $17.0M | $6.1M |
| FY2025 | $1.5M | $13.8M | $7.6M |